Physicians' Academy for Cardiovascular Education
Click here to watch this as part of CME accredited course

Key classes of antidiabetic drugs – How do they work?

5 Things a cardiologist needs to know about diabetes

10' education - Feb. 14, 2018 - Prof Cliff Bailey - Birmingham, UK - Online CME

5 Things a cardiologist needs to know about diabetes Multiple causal pathways contribute to development of T2DM, thus various processes may be targeted to improve glucose regulation. Prof. Bailey briefly summarises the available therapeutic options.

Click here to watch this as part of CME accredited course

Video navigation menu

  • Aspects to consider after diagnosing T2DM 0:34
  • Multiple causes contribute to development of T2DM 1:31
  • Managing hyperglycaemia: lifetstyle interventions and oral agents 2:51
  • Injectable agents to treat T2DM 5:11
  • Concluding remarks 7:24

Educational information

This educational video is part of a series called '5 Things a cardiologist needs to know about diabetes' that are aimed to guide cardiologists in management of patients with type 2 diabetes, since the cardiology practice is increasingly confronted with these patients. This series covers five topics that help cardiologists understand what is important when treating patients with diabetes, and what risks these patients face.

This recording was developed under auspices of PACE-cme. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-cme.

Faculty

Clifford J. Bailey, PhD, FRCP, FRCPath is a Professor of Clinical Science at School of Life & Health Sciences, Aston University in Birmingham, UK. His research interest includes the pathogenesis of diabetes mellitus and obesity, and the development of new therapies, with a specifc interest in the pathogenesis and interventional approaches against insulin resistance and discovery and development of agents to treat diabetes and obesity.

Disclosures

This educational series is funded by an unrestricted educational grant provided by Merck & Pfizer.

Share this page with your colleagues and friends: